1. MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
   Fatima Ghamlouche et al, 2023, Translational Oncology CrossRef
2. Chimeric nanocomposites for the rapid and simple isolation of urinary extracellular vesicles
   Thuy Nguyen Thi Dao et al, 2022, Journal of Extracellular Vesicles CrossRef
3. AMPK’s double-faced role in advanced stages of prostate cancer
   Faeze Gharibpoor et al, 2022, Clinical and Translational Oncology CrossRef
4. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
   Mehrdad Hashemi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
5. The Role of PKM2 in the Regulation of Mitochondrial Function: Focus on Mitochondrial Metabolism, Oxidative Stress, Dynamic, and Apoptosis. PKM2 in Mitochondrial Function
   Jing Gao et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
6. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
   Xuan Ni et al, 2024, Acta Pharmacologica Sinica CrossRef
7. Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods
   Elena Pudova et al, 2023, Life CrossRef
8. Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications
   Peng Chen et al, 2024, Current Medicinal Chemistry CrossRef
9. The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
   Chang Liu et al, 2021, Frontiers in Oncology CrossRef
10. Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells
    Junming Peng et al, 2022, Cell Communication and Signaling CrossRef
11. Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/NOTCH1
    Nan-nan Chen et al, 2024, Molecular and Cellular Probes CrossRef